circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1

Liang,Hongguang; Lin,Zelong; Lin,Huiwen; Zhao,Li; Huang,Weihua

doi:10.3892/etm.2021.10366

circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1

Authors:
- Hongguang Liang
- Zelong Lin
- Huiwen Lin
- Li Zhao
- Weihua Huang
View Affiliations

Affiliations: Department of Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510168, P.R. China, Department of Thoracic Surgery, Traditional Chinese Medicine‑Integrated Hospital, Southern Medical University, Guangzhou, Guangdong 510315, P.R. China
Published online on: July 1, 2021 https://doi.org/10.3892/etm.2021.10366
Article Number: 934
Copyright: © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is one of the main causes of tumor lethality worldwide. Circular RNAs (circRNAs) have essential roles in tumor progression. However, in non‑small cell lung carcinoma (NSCLC), the role of circRNAs remains unknown. In the present study, the expression, function and molecular mechanisms of a new circRNA, circRNA_103615, were investigated in NSCLC. Reverse transcription‑quantitative PCR (RT‑qPCR) was used to detect circRNA_103615 expression levels in NSCLC and normal tissues, as well as in NSCLC cell lines. MTT assay, flow cytometric assay, colony formation assay, and cell migration and invasion assays were used to examine the function of circRNA_103615 in NSCLC cells. MTT assay, colony formation assay, RT‑qPCR, and western blotting were used to detect the effect of circRNA_103615 on cisplatin resistance. The results demonstrated that NSCLC cell lines and tissues had increased levels of circRNA_103615 compared with normal cells and normal tissues, respectively. Functionally, silencing of circRNA_103615 by small interfering RNA resulted in suppression of cell growth, migration, and invasion, but promotion of cell apoptosis. In addition, the cisplatin resistance of NSCLC was reversed by the silencing of circRNA_103615. Notably, ATP binding cassette subfamily Bmember 1 (ABCB1) expression was significantly decreased following circRNA_103615 knockdown, and ABCB1 overexpression reversed the effects of circRNA_103615 silencing on NSCLC cisplatin resistance. Thus, the present study indicated that circRNA_103615 may serve as a critical oncogene and potential novel biomarker in NSCLC, as well as a potential cisplatin resistance promoter, by regulating ABCB1 expression.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
2	Chang A: Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer. 71:3–10. 2011.PubMed/NCBI View Article : Google Scholar
3	Jeremic B, Milicic B, Dagovic A, Aleksandrovic J and Nikolic N: Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol. 129:114–122. 2003.PubMed/NCBI View Article : Google Scholar
4	Yano T, Okamoto T, Fukuyama S and Maehara Y: Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin Oncol. 5:1048–1054. 2014.PubMed/NCBI View Article : Google Scholar
5	Kondo S, Iwata S, Yamada T, Inoue Y, Ichihara H, Kichikawa Y, Katayose T, Souta-Kuribara A, Yamazaki H, Hosono O, et al: Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer. Clin Cancer Res. 18:6326–6338. 2012.PubMed/NCBI View Article : Google Scholar
6	Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 19:141–157. 2013.PubMed/NCBI View Article : Google Scholar
7	Zhang HD, Jiang LH, Sun DW, Hou JC and Ji ZL: circRNA: A novel type of biomarker for cancer. Breast Cancer. 25:1–7. 2018.PubMed/NCBI View Article : Google Scholar
8	Yao Z, Luo J, Hu K, Lin J, Huang H, Wang Q, Zhang P, Xiong Z, He C, Huang Z, et al: ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Mol Oncol. 11:422–437. 2017.PubMed/NCBI View Article : Google Scholar
9	Tian M, Chen R, Li T and Xiao B: Reduced expression of circRNA hsa_circ_0003159 in gastric cancer and its clinical significance. J Clin Lab Anal. 32(e22281)2018.PubMed/NCBI View Article : Google Scholar
10	Du WW, Fang L, Yang W, Wu N, Awan FM, Yang Z and Yang BB: Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 24:357–370. 2017.PubMed/NCBI View Article : Google Scholar
11	Yang C, Yuan W, Yang X, Li P, Wang J, Han J, Tao J, Li P, Yang H, Lv Q and Zhang W: Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Mol Cancer. 17(19)2018.PubMed/NCBI View Article : Google Scholar
12	Gong Y, Mao J, Wu D, Wang X, Li L, Zhu L and Song R: Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6. Cancer Cell Int. 18(116)2018.PubMed/NCBI View Article : Google Scholar
13	Yao JT, Zhao SH, Liu QP, Lv MQ, Zhou DX, Liao ZJ and Nan KJ: Over-expression of circRNA_100876 in non-small cell lung cancer and its prognostic value. Pathol Res Pract. 213:453–456. 2017.PubMed/NCBI View Article : Google Scholar
14	Zhu Q, Lu G, Luo Z, Gui F, Wu J, Zhang D and Ni Y: circRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun. 497:626–632. 2018.PubMed/NCBI View Article : Google Scholar
15	Xia W, Qiu M, Chen R, Wang S, Leng X, Wang J, Xu Y, Hu J, Dong G, Xu PL and Yin R: Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation. Sci Rep. 6(35576)2016.PubMed/NCBI View Article : Google Scholar
16	Huang X, Li Z, Zhang Q, Wang W, Li B, Wang L, Xu Z, Zeng A, Zhang X, Zhang X, et al: Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Mol Cancer. 18(71)2019.PubMed/NCBI View Article : Google Scholar
17	Qi Y, Zhang B, Wang J and Yao M: Upregulation of circular RNA hsa_circ_0007534 predicts unfavorable prognosis for NSCLC and exerts oncogenic properties in vitro and in vivo. Gene. 676:79–85. 2018.PubMed/NCBI View Article : Google Scholar
18	Jiang MM, Mai ZT, Wan SZ, Chi YM, Zhang X, Sun BH and Di QG: Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis. J Cancer Res Clin Oncol. 144:667–674. 2018.PubMed/NCBI View Article : Google Scholar
19	Jin X, Feng CY, Xiang Z, Chen YP and Li YM: circRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of nonalcoholic steatohepatitis. Oncotarget. 7:66455–66467. 2016.PubMed/NCBI View Article : Google Scholar
20	Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 56:55–66. 2014.PubMed/NCBI View Article : Google Scholar
21	Cui J, Li W, Liu G, Chen X, Gao X, Lu H and Lin D: A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f. Artif Cells Nanomed Biotechnol. 47:810–821. 2019.PubMed/NCBI View Article : Google Scholar
22	Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S and Yuan H: Microarray profile of circular RNAs identifies hsa_circ_0014130 as a new circular RNA biomarker in non-small cell lung cancer. Sci Rep. 8(2878)2018.PubMed/NCBI View Article : Google Scholar
23	Zhao F, Han Y, Liu Z, Zhao Z, Li Z and Jia K: circFADS2 regulates lung cancer cells proliferation and invasion via acting as a sponge of miR-498. Biosci Rep. 38(BSR20180570)2018.PubMed/NCBI View Article : Google Scholar
24	Liu T, Song Z and Gai Y: Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p. Biochem Biophys Res Commun. 503:1503–1509. 2018.PubMed/NCBI View Article : Google Scholar